Advancing Molecular Radiotherapy with MIM SurePlan™ MRT
MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for molecular radiotherapy.
- Multi-tracer theranostics support.
- Quantitative SPECT and planar corrections.
- Auto-ROI generation for liver and kidney.
- Timesaving tools for organ and tumor VOI generation.
MIM SurePlan MRT's atlas segmentation can significantly reduce the time required to generate organ volumes including the liver and kidney. Industry-leading segmentation tools are also available for tumors and other volumes of interest.
Easily Incorporate Multiple Modalities
Multiple modality image fusion is available, allowing comparison of PET, SPECT, CT, and MRI. Deformable image registration is also included for cases where there are differences in positioning, size, and organ movement.
Quantitative Image Corrections
MIM SurePlan MRT includes quantitative SPECT reconstruction with SPECTRA™ Quant and quantitative planar image corrections to provide activity concentration measurements for time-activity curve generation and dosimetry calculations.
MIM SurePlan MRT provides tools for voxel-based absorbed dose calculation for molecular radiotherapy. MIM SurePlan MRT can calculate isodose curves/DVH on SPECT using the voxel s-value (VSV) schema in MIRD Pamphlet No. 17. Therapy response evaluation is possible with automated tools for serial exam comparison.
MIM SurePlan MRT offers an integrated reporting solution that allows for incorporation of images and statistics into reports to better describe the treatment course. Dictated text can be pulled into reports from PowerScribe® 360 and exported to PDF or DICOM structured reports.